CTI Bites Off Big Chunk Of Myelofibrosis Market With Vonjo Approval

 
• By Alaric DeArment
  
FDA Approved
CTI won its first FDA approval, with the agency giving its nod to the myelofibrosis drug Vonjo • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip